These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12721257)
1. CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. Clarke M; Gaynon P; Hann I; Harrison G; Masera G; Peto R; Richards S; J Clin Oncol; 2003 May; 21(9):1798-809. PubMed ID: 12721257 [TBL] [Abstract][Full Text] [Related]
2. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials. Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952 [TBL] [Abstract][Full Text] [Related]
3. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group. Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Hill FG; Richards S; Gibson B; Hann I; Lilleyman J; Kinsey S; Mitchell C; Harrison CJ; Eden OB; Br J Haematol; 2004 Jan; 124(1):33-46. PubMed ID: 14675406 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience. Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215 [TBL] [Abstract][Full Text] [Related]
6. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC; Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508 [TBL] [Abstract][Full Text] [Related]
9. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study. Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M; Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378 [TBL] [Abstract][Full Text] [Related]
10. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation. Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790 [TBL] [Abstract][Full Text] [Related]
11. High-dose methotrexate in childhood all. Moe PJ; Holen A Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393 [TBL] [Abstract][Full Text] [Related]
12. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis? Jastaniah W; Elimam N; Abdalla K; Khattab TM; Felimban S; Abrar MB Hematology; 2015 Dec; 20(10):561-6. PubMed ID: 26010408 [TBL] [Abstract][Full Text] [Related]
13. Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16. Jeha S; Pei D; Choi J; Cheng C; Sandlund JT; Coustan-Smith E; Campana D; Inaba H; Rubnitz JE; Ribeiro RC; Gruber TA; Raimondi SC; Khan RB; Yang JJ; Mullighan CG; Downing JR; Evans WE; Relling MV; Pui CH J Clin Oncol; 2019 Dec; 37(35):3377-3391. PubMed ID: 31657981 [TBL] [Abstract][Full Text] [Related]
14. Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12. Manabe A; Tsuchida M; Hanada R; Ikuta K; Toyoda Y; Okimoto Y; Ishimoto K; Okawa H; Ohara A; Kaneko T; Koike K; Sato T; Sugita K; Bessho F; Hoshi Y; Maeda M; Kinoshita A; Saito T; Tsunematsu Y; Nakazawa S J Clin Oncol; 2001 Jul; 19(13):3182-7. PubMed ID: 11432884 [TBL] [Abstract][Full Text] [Related]
15. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature]. Zając-Spychała O; Wachowiak J Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657 [TBL] [Abstract][Full Text] [Related]
16. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview]. Thomas X; Pavan L; Le QH Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650 [TBL] [Abstract][Full Text] [Related]
17. Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia. Dördelmann M; Reiter A; Zimmermann M; Fengler R; Henze G; Riehm H; Schrappe M J Pediatr Hematol Oncol; 1998; 20(5):444-50. PubMed ID: 9787317 [TBL] [Abstract][Full Text] [Related]
18. Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group. Thyss A; Suciu S; Bertrand Y; Mazingue F; Robert A; Vilmer E; Mechinaud F; Benoit Y; Brock P; Ferster A; Lutz P; Boutard P; Marguerite G; Plouvier E; Michel G; Plantaz D; Munzer M; Rialland X; Chantraine JM; Norton L; Solbu G; Philippe N; Otten J J Clin Oncol; 1997 May; 15(5):1824-30. PubMed ID: 9164191 [TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Richards S; Pui CH; Gayon P; Pediatr Blood Cancer; 2013 Feb; 60(2):185-95. PubMed ID: 22693038 [TBL] [Abstract][Full Text] [Related]
20. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922. Tolar J; Bostrom BC; La MK; Sather HN Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]